User profiles for S. Chawla

sanjay chawla

- Verified email at sydney.edu.au - Cited by 12430

Shuchi Chawla

- Verified email at cs.wisc.edu - Cited by 7908

Saurabh Chawla

- Verified email at emory.edu - Cited by 1658

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature

SN Chawla, PL Crispen, AL Hanlon… - The Journal of …, 2006 - auajournals.org
… The physician assuming responsibility for observing the lesion(s) should directly review
and compare the studies. With regard to the interval of imaging we believe that it is prudent to …

[HTML][HTML] COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

…, M Matrana, N Agarwal, S Chawla, S Kato… - Nature reviews Clinical …, 2021 - nature.com
… counts, particularly neutropenia, lymphopenia and thrombocytopenia, according to local
practices at each hospital and the treating physician’s judgement in the patient’s best interest. …

Modifiable and non-modifiable risk factors for pancreatic cancer: A review

S Midha, S Chawla, PK Garg - Cancer letters, 2016 - Elsevier
Pancreatic ductal adenocarcinoma is associated with a poor prognosis and a high case-fatality
rate. The reasons for poor prognosis are low rates of curative resection due to local …

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim… - The Lancet, 2012 - thelancet.com
Background Pazopanib, a multitargeted tyrosine kinase inhibitor, has single-agent activity in
patients with advanced non-adipocytic soft-tissue sarcoma. We investigated the effect of …

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

…, T Seto, BC Cho, D Tosi, B Besse, SP Chawla… - The Lancet …, 2020 - thelancet.com
Background Entrectinib is a potent inhibitor of tropomyosin receptor kinase (TRK) A, B, and
C, which has been shown to have anti-tumour activity against NTRK gene fusion-positive …

Deep learning for anomaly detection: A survey

R Chalapathy, S Chawla - arXiv preprint arXiv:1901.03407, 2019 - arxiv.org
Anomaly detection is an important problem that has been well-studied within diverse research
areas and application domains. The aim of this survey is two-fold, firstly we present a …

Correlation clustering

N Bansal, A Blum, S Chawla - Machine learning, 2004 - Springer
… that each Ai is either a subset of S or contains exactly one of the … First, we consider the case
when Ai ⊆ S. Now during the … cluster of size s reduces our objective function by at most ( s

Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme

EI Zacharaki, S Wang, S Chawla… - … in Medicine: An …, 2009 - Wiley Online Library
… (t) = −ln(S(t)/S 0 )/TE, where S(t) is signal intensity at time t and S 0 is baseline signal intensity…
where s controls the size of the gaussian kernel. We defined s to be adaptive to the number …

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

P Schöffski, S Chawla, RG Maki, A Italiano… - The Lancet, 2016 - thelancet.com
Background A non-randomised, phase 2 study showed activity and tolerability of eribulin in
advanced or metastatic soft-tissue sarcoma. In this phase 3 study, we aimed to compare …

Learning from labeled and unlabeled data using graph mincuts

A Blum, S Chawla - 2001 - kilthub.cmu.edu
… ÚÖ Ñ ×º ÑÙº Ù Shuchi Chawla … Therefore, the labeling that minimizes the value of the cut
also minimizes 's … Roy, S., & Cox, IJ (1998). A maximum-flow formulation of the n-camera ×tereo …